Pyridam Farma Tbk PT
IDX:PYFA
Pyridam Farma Tbk PT
Accrued Liabilities
Pyridam Farma Tbk PT
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Accrued Liabilities
Rp291.7B
|
CAGR 3-Years
123%
|
CAGR 5-Years
129%
|
CAGR 10-Years
59%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Accrued Liabilities
Rp130.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Accrued Liabilities
Rp891.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Accrued Liabilities
Rp452.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Accrued Liabilities
Rp202.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Accrued Liabilities
Rp1.2T
|
CAGR 3-Years
122%
|
CAGR 5-Years
55%
|
CAGR 10-Years
29%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Accrued Liabilities?
Accrued Liabilities
291.7B
IDR
Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Accrued Liabilities amounts to 291.7B IDR.
What is Pyridam Farma Tbk PT's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
59%
Over the last year, the Accrued Liabilities growth was 196%. The average annual Accrued Liabilities growth rates for Pyridam Farma Tbk PT have been 123% over the past three years , 129% over the past five years , and 59% over the past ten years .
